NeeharDilipParikhMD

PubMed

• 557 citations
  Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study
  Elliot B. Tapper, Neehar D. Parikh
  BMJ. 2018-07-18
• 3 citations
  Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study.
  Jagpreet Chhatwal, Sumeyye Samur, Ju Dong Yang, Lewis R Roberts, Mindie H Nguyen
  Hepatology Communications. 2023-06-01
• 15 citations
  International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance.
  Amit G Singal, Marco Sanduzzi-Zamparelli, Pierre Nahon, Maxime Ronot, Yujin Hoshida
  Journal of Hepatology. 2023-07-01

Journal Articles

• Frailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated with Poor Patient‐Reported Outcomes in Cirrhosis  
  Elliot B Tapper, Neehar D Parikh, Anna S Lok, Hepatology
• Effectiveness and Cost of Radiofrequency Ablation and Stereotactic Body Radiotherapy for Treatment of Early‐Stage Hepatocellular Carcinoma: An Analysis of SEER‐Medicare  
  Amit G Singal, Neehar D Parikh, Theodore S Lawrence, Nataliya Razumilava, Journal of Medical Imaging and Radiation Oncology
• Radiologist Quality Assurance by Nonradiologists at Tumor Board  
  William R Masch, Neehar D Parikh, Journal of the American College of Radiology

Books/Book Chapters

• Controversies in Hepatology: The Experts Analyze Both Sides 
  Chapter: NAFLD: To Biopsy or Not to Biopsy 
  Parikh ND, Van Wagner L, Rinella MEditors: Donald Jensen, MD.PNS & WSS Incorporated dba SLACK Incorporated, Delaware Corporation, Thorofare, NJ,2011

Abstracts/Posters

• Analytic Morphomics Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
  Parikh ND, Singal AG, Zhang P, Krishnamurthy V, Barman P, Waljee AK, Su GL, American Association for the Study of Liver Diseases Meeting, San Francisco, CA, 1/1/2015
• Prevalence of hepatitis B core antibody (anti-HBc) and association with hepatocellular carcinoma (HCC) in patients with chronic hepatitis C virus (HCV) infection in th...
  Yang M, Wu E, Fu S, Rao H, Feng B, Lin A, Fei R, Parikh ND, Fontana RJ, Lok AS, Wei L, American Association for the Study of Liver Diseases Meeting, San Francisco, CA, 1/1/2015
• Survival Of Patients With Advanced Hepatocellular Carcinoma On Sorafenib: An Analysis Of SEER-Medicare Database
  Parikh ND, Marshall V, Balkrishnan R, Shahinian V, International Liver Cancer Association Annual Conference, Paris, France, 1/1/2015
• Sorafenib Use In Elderly Patients With Advanced Hepatocellular Carcinoma In The United States: An Analysis Of The Seer-Medicare Database
  Parikh ND, Marshall V, Shahinian V, Balkrishnan R, International Liver Cancer Association Annual Conference, Paris, France, 1/1/2015
• Evaluation of Hypoglycemia in a Randomized Controlled Trial Comparing Moderate to Intensive Glycemic Control Post-Liver Transplant
  Welsh N, Derby T, Gupta S, Fulkerson C, Oakes DJ, Schmidt K, Parikh N, Norvell JP, Levitsky J, Molitch ME, Wallia A, American Diabetes Association Annual Meeting, Boston, MA, 1/1/2015
• Survival Of Patients With Advanced Hepatocellular Carcinoma Treated with Sorafenib: An Analysis Of SEER-Medicare Database
  Parikh ND, Marshall VD, Nathan H, Balkrishnan R, Shahinian V, American Association for the Study of Liver Diseases Meeting, San Francisco, CA, 1/1/2015
• Projections of US Donor Organ Availability for Liver Transplantation
  Parikh ND, Hutton D, Sanghani K, Xu Y, Lavieri M, World Transplant Congress, San Francisco, CA, 1/1/2014
• Outcomes of Orthopedic Procedures in Patients with Cirrhosis
  Parikh ND, Levitsky J, Stover M, Lapin B, American Association for the Study of Liver Diseases Meeting, Washington, DC, 1/1/2013
• Predictors and Survival of Redo Simultaneous Liver-Kidney Transplantation versus Redo Liver Alone Transplantation
  Parikh ND, Lapin B, Baker TB, American Association for the Study of Liver Diseases Meeting, Washington, DC, 1/1/2013
• Higher Sustained Virologic Response (SVR-12) Achievable in Liver Transplant Recipients with Hepatitis C (HCV) Treated with Protease Inhibitor (PI) Triple Therapy (TT)
  Stravitz RT, Levitsky J, Dodge J, Saxena V, Burton JR, Verna EC, O’Leary JG, Parikh ND, Everson GT, Brown R, Trotter J, Terrault NA, American Association for the Study of Liver Diseases Meeting, Washington, DC, 1/1/2013
• Performing Weekend ERCP is Associated with a Reduction in Hospital Charges and Length of Stay
  Issaka RB, Parikh ND, Komanduri S, Martin JA, Keswani RN, Digestive Diseases Week Meeting, Orlando, FL, 1/1/2013
• Time on Waiting List for Patients with High MELD Does Not Influence Graft or Patient Survival After Liver Transplantation
  Parikh ND, Lapin B, Abecassis MM, Baker T, American Transplant Congress, Seattle, WA, 1/1/2013
• Efficacy and safety of venting percutaneous endoscopic gastrostomy (VPEG) tube placement in patients with malignant obstruction
  Issaka RB, Shapiro DM, Parikh ND, Mulcahy MF, Komanduri S,. Martin JA, Keswani RN, Gastrointestinal Cancers Symposium, San Francisco, CA, 1/1/2013
• A Probabilistic Model of the Natural History of Hepatocellular Carcinoma
  Parikh ND, Baker T, Ladner DP, Skaro A, Cahan J, Salem R, Kulik L, Mulcahy M, Abecassis MM, Hazen G, American Association for the Study of Liver Diseases Meeting, Boston, MA, 1/1/2012
• The Utility of HIT Testing in Patients with Cirrhosis
  Kia L, Martin K, Parikh ND, Kulik L, McMahon B, Digestive Diseases Week Meeting, San Diego, CA, 1/1/2012
• Comprehensive Colorectal Cancer Screening in an Underserved, Ethnically Diverse Population
  Parikh, ND, Gawron A, Fought A, Waldman B, Hasnain-Wynia R, Jung B, AcademyHealth Annual Reseach Meeting, Orlando, FL, 1/1/2012
• Clinical Outcomes and Quality of Life in Recipients of Livers Donated After Cardiac Death
  Parikh ND, Skaro AI, Ladner D, Lyuksemberg V, Cahan JG, Daud A, Abecassis MM, Butt Z, American Association for the Study of Liver Diseases Meeting, San Francisco, CA, 1/1/2011
• Trends in BMI and Organ Utilization in Cadaveric Liver Donation
  Parikh ND, Rinella ME, Frunk B, Koppe S, American Association for the Study of Liver Diseases Meeting, San Francisco, CA, 1/1/2011
• The effects of the 2003 Health Resources and Services Administration mandate on liver donation after cardiac death on organ procurement
  Parikh ND, Frunk B, Skaro AI, American Association for the Study of Liver Diseases Meeting, San Francisco, CA, 1/1/2011
• Low serum globulin level is a risk factor for spontaneous bacterial peritonitis
  Kia L, Siddiqui MS, Bulsiewicz WJ, Henkel A, Parikh ND, American Association for the Study of Liver Diseases Meeting, San Francisco, CA, 1/1/2011
• A Simulated Randomized Control Trial of Endoscopic Clip Placement to Prevent Delayed Bleeding after Colonic Polypectomy On and Off Anticoagulation
  Parikh ND, Young RS, Gawron A, American College of Gastroenterology Annual Meeting, Washington, DC, 1/1/2011
• Prevalence and predictors of sub-optimal liver recipient quality of life
  Butt, Z., Parikh ND, Lyuksemburg, V., Daud, A., Lee, J., & Ladner, D, American Transplant Congress, Philadelphia, PA, 1/1/2011
• Morbidity and Mortality of TIPS Placement in the Elderly is no Different than in Younger Age Groups
  Parikh ND, Blei A, Flamm S, Digestive Diseases Week Meeting, San Diego, CA, 1/1/2008
• Hyperglycemia after Liver Transplantation is Associated with an Increased Risk of Allograft Rejection
  Parikh ND, Wallia A, Tian L, O’Shea-Mahler E, Molitch M, Levitsky J, American Transplant Congress, Toronto, Canada, 1/1/2008
• 63 year old female presents with painless jaundice
  Parikh ND, Kulik, L, Midwest Society of General Internal Medicine, Annual Meeting, Chicago, IL, 1/1/2006
• Join now to see all

Lectures

• Comparative efficacy of second-line treatments for advanced hepatocellular carcinoma: A network meta-analysis. 
  ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
• Reinterpretation of outside hospital MRI abdomen exams in patients with cirrhosis: Is the OPTN mandate necessary? 
  Waikoloa, HI - 1/1/2016
• The Impact of US Population Demographic Shifts on Organ Availability for Transplantation 
  1/1/2015
• Medical Management of Advanced HCC: Cost Vs Benefits 
  Novi, MI - 1/1/2015
• The Liver Meeting 2015: Updates on Hepatic Malignancies and Liver Transplantation 
  Novi, MI - 1/1/2015
• Region-Based Projections of Deceased Liver Donors from 2015-2025: An Analysis of Proposed UNOS Liver Allocation Redistricting 
  San Francisco, CA - 1/1/2015
• The Diagnosis and Treatment of Hepatocellular Carcinoma 
  1/1/2015
• Forecasting the National Deceased Donor Organ Availability for Liver Transplantation 
  San Francisco, CA - 1/1/2014
• Outcomes Following Downstaging Of Hepatocellular Carcinoma For Liver Transplantation: A Meta Analysis 
  Kyoto, Japan - 1/1/2014
• Indications and Outcomes with Liver Transplantation for Hepatocellular Carcinoma 
  Novi, MI - 1/1/2014
• The Management of Complications from Portal Hypertension 
  Grand Rapids, MI - 1/1/2014
• The Liver Meeting 2014: Updates on Hepatic Malignancies 
  Novi, MI - 1/1/2014
• Therapies for Hepatocellular Carcinoma: A Secondary Analysis of the SEER-Medicare Data Set 
  1/1/2014
• Clinical Outcomes and Quality of Life in Recipients of Livers Donated After Cardiac Death 
  San Francisco, CA - 1/1/2013
• The Liver Meeting 2013: Updates on Hepatic Malignancies 
  Novi, MI - 1/1/2013
• I Want to Do More than Scope – What Are My Options? 
  1/1/2013
• Palliative Venting Percutaneous Endoscopic Gastrostomy (VPEG) Tube Placement is Safe and Effective in Patients with Malignant Obstruction: 13-Year Experience at a Tert... 
  San Diego, CA - 1/1/2012
• Modeling Medical Decision Making: Examples in Hepatocellular Carcinoma 
  1/1/2012
• Development and Validation of a Symptom Index for Advanced Hepatobiliary Cancers: The NCCN-FACT Hepatobiliary Symptom Index 
  San Diego, CA - 1/1/2012
• Comprehensive Colorectal Cancer Screening in an Underserved, Ethnically Diverse Population 
  Orlando, FL - 1/1/2012
• Random Effects ANOVA for Testing Heterogeneity of Brownian Motion Cancer Growth 
  Phoenix, AZ - 1/1/2012
• The Effect of Donor-Recipient Age Difference on Outcomes after Liver Transplantation. 
  Boston, MA - 1/1/2012
• It is Ethical to Deny Liver Transplantation to Patients with Acute Alcoholic Hepatitis 
  1/1/2012
• A Novel Renal Injury Proteomic Biomarker Panel Predicts Reversibility of Renal Dysfunction Following Liver Transplantation 
  Philadelphia, PA - 1/1/2011
• Join now to see all